Home   >  
Protease/Metabolic Enzyme
  • Cell Cycle/DNA Damage
  >  
HSP
  >   PF-04929113 Mesylate
PF-04929113 Mesylate Chemical Structure

PF-04929113 Mesylate

Data Sheet For research use only. Not for human use.
Cat. No. :BCP17210CAS No. :1173111-67-5Purity:98%
 Tel: 0086-17754423994   or   orders@biochempartner.com
Real-Time Inquiry ×

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • Chemical Properties&Biological Activity
CAS No. 1173111-67-5 Cat. No. BCP17210
Name PF-04929113 Mesylate
Synonyms PF04929113 Mesylate;PF 04929113 Mesylate;SNX5422 Mesylate;SNX-5422 Mesylate;SNX 5422 Mesylate;
SMILES
Chemical Name
Formula C26H34F3N5O7S M. Wt 617.64
Purity 98% Storage Store at 4-8°C
Description in vitro: PF-04929113 is a small-molecule Hsp90 inhibitor based on the 6,7-dihydro-indazol-4-one scaffold. PF-04929113 developed by Serenex, converts to SNX-2122, which is the active Hsp90 inhibitor form. PF-04929113 exhibits potent effects on Her-2 stability and causes expected up-regulation of Hsp70. PF-04929113 shows potent antiproliferative activity against a broad range of cancer cell types, e.g. MCF-7 (IC50=16 nM), SW620 (IC50=19 nM), K562 (IC50=23 nM), SK-MEL-5 (IC50=25 nM), and A375 (IC50=51 nM). in vivo: PF-04929113 inhibits human MM cell growth in vivo, and immuno-histochemical analysis shows PF-04929113 significantly inhibits p-ERK and p-Akt in treated mice. Meanwhile, PF-04929113 treatment significantly decreases the percentage of CD31+ cells and MVD, consistent with an inhibitory effect on angiogenesis in vivo. A 50 mg/kg administration of PF-04929113 delivered 3 times per week significantly delays castrate-resistant LNCaP tumor growth and prolongs cancer specific survival
  • Quality Control&Technical Support
In the process of purchasing and using Biochempartner products, you can consult us if you have any problems: orders@biochempartner.com. We will try our best to solve all your doubts.

Recommend Products

More >

Tags:PF-04929113 Mesylate supplier,PF-04929113 Mesylate purchase,PF-04929113 Mesylate manufacturer,PF-04929113 Mesylate distributor,PF-04929113 Mesylate cost,PF-04929113 Mesylate buy,PF-04929113 Mesylate for sale

0086-13720134139